Leidos

US · LDOS #1114 by market cap Listed 1970

113.55 -3.14 -2.69%

Live - 5344 symbols - heartbeat 96s ago · 2026-10-08 06:06

Pre-market 112.11 -1.27%

After-hours 113.55 0.00%

Overnight 112.87 -0.60%

Market cap: 14.25B
P/E (TTM): 10.60
P/B: 2.70
EPS: 11.14
Div yield: 1.49%
52W pos: 14%

Reader sentiment Are you bullish or bearish on LDOS?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 3.45, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +3.07% YoY

Margins

Gross margin: 18.04%
Operating margin: 12.23%
Net margin: 8.43%

Key ratios & quality

Enterprise value: 17.79B
PEG ratio: 0.37
Altman Z-Score: 3.45

PEG uses trailing P/E against the 3-year net income growth rate (28.34%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2020	2020	2021	2022	2023	2025	2026
Revenue	10.19B	11.09B	12.30B	13.74B	14.40B	15.44B	16.66B	17.17B
Gross profit	1.50B	1.55B	1.74B	2.01B	2.08B	2.24B	2.80B	3.10B
Selling & admin expenses	729.00M	689.00M	770.00M	851.00M	951.00M	942.00M	983.00M	999.00M
Research & development	--	--	--	--	--	--	--	--
Operating profit	775.00M	859.00M	967.00M	1.16B	1.13B	1.30B	1.82B	2.10B
Pretax profit	610.00M	866.00M	781.00M	967.00M	886.00M	403.00M	1.64B	1.91B
Tax	28.00M	196.00M	152.00M	208.00M	193.00M	195.00M	388.00M	447.00M
Net profit	582.00M	670.00M	629.00M	759.00M	693.00M	208.00M	1.25B	1.46B
Basic EPS	4	5	4	5	5	1	9	11
Diluted EPS	3.80	4.60	4.36	5.27	4.96	1.44	9.22	11.14

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Revenue	4.25B	4.25B	4.47B	4.21B	4.40B	4.56B
Gross profit	757.00M	782.00M	821.00M	739.00M	761.00M	817.00M
Selling & admin expenses	230.00M	217.00M	286.00M	266.00M	223.00M	283.00M
Research & development	--	--	--	--	--	--
Operating profit	527.00M	565.00M	535.00M	473.00M	538.00M	534.00M
Pretax profit	478.00M	518.00M	484.00M	429.00M	429.00M	451.00M
Tax	113.00M	125.00M	115.00M	94.00M	94.00M	95.00M
Net profit	365.00M	393.00M	369.00M	335.00M	335.00M	356.00M
Basic EPS	3	3	3	3	3	3
Diluted EPS	2.77	3.01	2.82	2.53	2.56	2.81

Balance sheet

Line item	2018	2020	2020	2021	2022	2023	2025	2026
Total current assets	2.84B	2.81B	3.34B	3.62B	3.64B	4.01B	4.33B	4.81B
Cash & ST investments	327.00M	668.00M	524.00M	727.00M	516.00M	777.00M	849.00M	1.11B
Inventory	--	72.00M	276.00M	274.00M	287.00M	310.00M	315.00M	342.00M
Total assets	8.77B	9.37B	12.51B	13.26B	13.07B	12.70B	13.01B	13.49B
Total current liabilities	2.06B	2.33B	2.91B	3.23B	3.95B	2.99B	3.56B	2.83B
Short-term debt	72.00M	61.00M	100.00M	483.00M	992.00M	18.00M	618.00M	20.00M
Long-term debt	3.05B	2.93B	4.64B	4.59B	3.93B	4.66B	4.05B	4.63B
Total liabilities	5,459,000,000.00	5,950,000,000.00	8,640,000,000.00	8,917,000,000.00	8,718,000,000.00	8,437,000,000.00	8,550,000,000.00	8,531,000,000.00
Total equity	3.31B	3.42B	3.87B	4.34B	4.35B	4.26B	4.46B	4.96B
Retained earnings	372.00M	896.00M	1.33B	1.88B	2.37B	2.36B	3.41B	4.65B

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Total current assets	4.55B	4.78B	4.85B	4.81B	4.40B	5.25B
Cash & ST investments	842.00M	930.00M	974.00M	1.11B	457.00M	748.00M
Inventory	347.00M	364.00M	360.00M	342.00M	336.00M	94.00M
Total assets	13.20B	13.55B	13.54B	13.49B	15.39B	15.63B
Total current liabilities	2.96B	2.95B	2.99B	2.83B	3.15B	3.22B
Short-term debt	119.00M	119.00M	19.00M	20.00M	320.00M	22.00M
Long-term debt	5.01B	4.99B	4.63B	4.63B	6.01B	6.01B
Total liabilities	8,895,000,000.00	8,842,000,000.00	8,588,000,000.00	8,531,000,000.00	10,323,000,000.00	10,296,000,000.00
Total equity	4.30B	4.71B	4.95B	4.96B	5.06B	5.34B
Retained earnings	3.72B	4.06B	4.38B	4.65B	4.92B	5.22B

Cash flow

Line item	2018	2020	2020	2021	2022	2023	2025	2026
Operating cash flow	768.00M	992.00M	1.33B	1.03B	992.00M	1.19B	1.44B	1.75B
Depreciation & amortization	257.00M	234.00M	282.00M	325.00M	333.00M	331.00M	290.00M	290.00M
Free cash flow	695.00M	871.00M	1.15B	929.00M	863.00M	980.00M	1.29B	1.63B
Dividends paid	-198.00M	-198.00M	-196.00M	-199.00M	-199.00M	-201.00M	-208.00M	-211.00M
Stock buybacks / issuance	-424.00M	-431.00M	-70.00M	-226.00M	-494.00M	-196.00M	-851.00M	-882.00M
Ending cash balance	369.00M	717.00M	687.00M	727.00M	516.00M	641.00M	849.00M	1.11B

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Operating cash flow	58.00M	486.00M	711.00M	495.00M	301.00M	793.00M
Depreciation & amortization	69.00M	72.00M	74.00M	75.00M	72.00M	81.00M
Free cash flow	36.00M	457.00M	680.00M	452.00M	270.00M	761.00M
Dividends paid	-53.00M	-52.00M	-51.00M	-55.00M	-55.00M	-55.00M
Stock buybacks / issuance	-513.00M	7.00M	-86.00M	-290.00M	-227.00M	-55.00M
Ending cash balance	842.00M	930.00M	974.00M	1.11B	457.00M	748.00M

Returns & efficiency

Line item	2018	2020	2020	2021	2022	2023	2025	2026
ROE %	17.40	19.85	17.26	18.47	15.95	4.68	29.12	31.05
ROA %	6.54	7.36	5.74	5.84	5.20	1.54	9.72	10.89
ROIC %	11.01	11.70	9.71	9.38	8.51	3.82	14.67	16.15
5-year avg ROE %	--	--	15.48	16.85	17.79	15.24	17.10	19.85
EBIT margin %	7.41	9.13	7.83	8.39	7.54	3.98	11.00	12.30
FCF / sales %	6.82	7.85	9.36	6.75	5.95	6.21	7.46	9.46
Current ratio	1.38	1.21	1.15	1.12	0.92	1.34	1.22	1.70
Quick ratio	1.07	1.03	0.92	0.90	0.73	1.07	0.98	1.35
Debt / assets	35.62	35.36	42.43	42.72	42.00	40.95	40.67	38.80
LT debt / equity	92.26	95.25	134.85	120.76	104.63	123.30	105.92	106.08
Interest coverage	5.21	6.89	5.29	6.23	5.45	2.90	9.49	10.40
Revenue CAGR (3Y) %	19.56	16.35	6.54	10.45	9.07	7.88	6.65	6.06
Net income CAGR (3Y) %	--	39.82	19.72	9.03	0.89	-31.82	18.53	28.34
FCF CAGR (3Y) %	17.70	27.52	37.27	10.16	-0.31	-5.22	11.45	23.49

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
ROE %	31.31	30.76	29.51	31.05	30.49	27.67
ROA %	10.25	10.60	10.45	10.89	9.89	9.43
ROIC %	15.24	15.54	15.67	16.15	14.34	13.94
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	11.47	11.95	11.87	12.30	11.94	11.43
FCF / sales %	6.99	7.52	7.72	9.46	10.73	12.27
Current ratio	1.54	1.62	1.62	1.70	1.40	1.63
Quick ratio	1.27	1.30	1.32	1.35	1.11	1.15
Debt / assets	43.46	42.08	38.61	38.80	45.13	42.08
LT debt / equity	131.95	119.76	106.13	106.08	132.14	124.07
Interest coverage	10.06	10.35	10.18	10.40	9.90	9.04
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Intelligence & Digital is the largest reported line at 32.89% of revenue, across 4 reported segments.
No single line clears half of revenue; Health is next at 23.83%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Intelligence & Digital32.89%

Health23.83%

Homeland22.33%

Defense20.95%

Quote time 2026-10-08 06:06:35 · For reference only, not investment advice and not tailored to your situation.